Associations between double-checking and medication administration errors: a direct observational study of paediatric inpatients.


Journal

BMJ quality & safety
ISSN: 2044-5423
Titre abrégé: BMJ Qual Saf
Pays: England
ID NLM: 101546984

Informations de publication

Date de publication:
04 2021
Historique:
received: 06 05 2020
revised: 18 06 2020
accepted: 02 07 2020
pubmed: 10 8 2020
medline: 16 10 2021
entrez: 10 8 2020
Statut: ppublish

Résumé

Double-checking the administration of medications has been standard practice in paediatric hospitals around the world for decades. While the practice is widespread, evidence of its effectiveness in reducing errors or harm is scarce. To measure the association between double-checking, and the occurrence and potential severity of medication administration errors (MAEs); check duration; and factors associated with double-checking adherence. Direct observational study of 298 nurses, administering 5140 medication doses to 1523 patients, across nine wards, in a paediatric hospital. Independent observers recorded details of administrations and double-checking (independent; primed-one nurse shares information which may influence the checking nurse; incomplete; or none) in real time during weekdays and weekends between 07:00 and 22:00. Observational medication data were compared with patients' medical records by a reviewer (blinded to checking-status), to identify MAEs. MAEs were rated for potential severity. Observations included administrations where double-checking was mandated, or optional. Multivariable regression examined the association between double-checking, MAEs and potential severity; and factors associated with policy adherence. For 3563 administrations double-checking was mandated. Of these, 36 (1·0%) received independent double-checks, 3296 (92·5%) primed and 231 (6·5%) no/incomplete double-checks. For 1577 administrations double-checking was not mandatory, but in 26·3% (n=416) nurses chose to double-check. Where double-checking was mandated there was no significant association between double-checking and MAEs (OR 0·89 (0·65-1·21); p=0·44), or potential MAE severity (OR 0·86 (0·65-1·15); p=0·31). Where double-checking was not mandated, but performed, MAEs were less likely to occur (OR 0·71 (0·54-0·95); p=0·02) and had lower potential severity (OR 0·75 (0·57-0·99); p=0·04). Each double-check took an average of 6·4 min (107 hours/1000 administrations). Compliance with mandated double-checking was very high, but rarely independent. Primed double-checking was highly prevalent but compared with single-checking conferred no benefit in terms of reduced errors or severity. Our findings raise questions about if, when and how double-checking policies deliver safety benefits and warrant the considerable resource investments required in modern clinical settings.

Sections du résumé

BACKGROUND
Double-checking the administration of medications has been standard practice in paediatric hospitals around the world for decades. While the practice is widespread, evidence of its effectiveness in reducing errors or harm is scarce.
OBJECTIVES
To measure the association between double-checking, and the occurrence and potential severity of medication administration errors (MAEs); check duration; and factors associated with double-checking adherence.
METHODS
Direct observational study of 298 nurses, administering 5140 medication doses to 1523 patients, across nine wards, in a paediatric hospital. Independent observers recorded details of administrations and double-checking (independent; primed-one nurse shares information which may influence the checking nurse; incomplete; or none) in real time during weekdays and weekends between 07:00 and 22:00. Observational medication data were compared with patients' medical records by a reviewer (blinded to checking-status), to identify MAEs. MAEs were rated for potential severity. Observations included administrations where double-checking was mandated, or optional. Multivariable regression examined the association between double-checking, MAEs and potential severity; and factors associated with policy adherence.
RESULTS
For 3563 administrations double-checking was mandated. Of these, 36 (1·0%) received independent double-checks, 3296 (92·5%) primed and 231 (6·5%) no/incomplete double-checks. For 1577 administrations double-checking was not mandatory, but in 26·3% (n=416) nurses chose to double-check. Where double-checking was mandated there was no significant association between double-checking and MAEs (OR 0·89 (0·65-1·21); p=0·44), or potential MAE severity (OR 0·86 (0·65-1·15); p=0·31). Where double-checking was not mandated, but performed, MAEs were less likely to occur (OR 0·71 (0·54-0·95); p=0·02) and had lower potential severity (OR 0·75 (0·57-0·99); p=0·04). Each double-check took an average of 6·4 min (107 hours/1000 administrations).
CONCLUSIONS
Compliance with mandated double-checking was very high, but rarely independent. Primed double-checking was highly prevalent but compared with single-checking conferred no benefit in terms of reduced errors or severity. Our findings raise questions about if, when and how double-checking policies deliver safety benefits and warrant the considerable resource investments required in modern clinical settings.

Identifiants

pubmed: 32769177
pii: bmjqs-2020-011473
doi: 10.1136/bmjqs-2020-011473
pmc: PMC7982937
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Pagination

320-330

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMJ Open. 2016 Oct 21;6(10):e011811
pubmed: 27797997
Arch Dis Child. 2000 Dec;83(6):492-7
pubmed: 11087283
Int J Nurs Pract. 2002 Dec;8(6):330-5
pubmed: 12390586
J Adv Nurs. 2014 Jun;70(6):1404-13
pubmed: 24224731
Arch Dis Child. 2012 Sep;97(9):833-7
pubmed: 22550322
BMJ Qual Saf. 2018 Aug;27(8):655-663
pubmed: 29317463
BMC Health Serv Res. 2018 Feb 17;18(1):123
pubmed: 29454347
Hum Factors. 2018 Nov;60(7):902-921
pubmed: 29939767
Implement Sci. 2014 Jan 08;9:1
pubmed: 24398253
Am J Health Syst Pharm. 2016 Aug 1;73(15):1167-73
pubmed: 27440623
BMJ Qual Saf. 2020 Jul;29(7):595-603
pubmed: 31391315
Drug Saf. 2019 Jan;42(1):13-25
pubmed: 30117051
Ann Emerg Med. 2018 Jan;71(1):74-82.e1
pubmed: 28669554
Health Serv Res. 2006 Aug;41(4 Pt 2):1654-76
pubmed: 16898984
J Eval Clin Pract. 2008 Aug;14(4):513-9
pubmed: 19133335
Scand J Caring Sci. 2015 Jun;29(2):297-306
pubmed: 25213297
BMC Pediatr. 2019 Dec 11;19(1):486
pubmed: 31829142
Am J Hosp Pharm. 1991 Dec;48(12):2611-6
pubmed: 1814201
Pediatrics. 2016 Dec;138(6):
pubmed: 27940663
Aust Clin Rev. 1992;12(2):77-83
pubmed: 1622350
J Nurs Adm. 2016 Mar;46(3):154-60
pubmed: 26866326
J Clin Nurs. 2010 Mar;19(5-6):728-35
pubmed: 20500316
Pediatrics. 2019 Feb;143(2):
pubmed: 30670581
Asia Pac J Oncol Nurs. 2019 Jul-Sep;6(3):246-252
pubmed: 31259220
BMJ Qual Saf. 2020 Jul;29(7):536-540
pubmed: 32071137
Arch Intern Med. 2010 Apr 26;170(8):683-90
pubmed: 20421552
J Nurs Manag. 2019 Mar;27(2):264-270
pubmed: 30178904
Stud Health Technol Inform. 2016;228:629-33
pubmed: 27577460

Auteurs

Johanna I Westbrook (JI)

Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia Johanna.westbrook@mq.edu.au.

Ling Li (L)

Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.

Magdalena Z Raban (MZ)

Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.

Amanda Woods (A)

Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.

Alain K Koyama (AK)

Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.

Melissa Therese Baysari (MT)

Faculty of Health Sciences, The University of Sydney, Sydney, New South Wales, Australia.

Richard O Day (RO)

St Vincent's Hospital, University of New South Wales Faculty of Medicine, Sydney, New South Wales, Australia.

Cheryl McCullagh (C)

Executive, The Sydney Children's Hospitals Network Randwick and Westmead, Sydney, New South Wales, Australia.

Mirela Prgomet (M)

Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.

Virginia Mumford (V)

Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.

Luciano Dalla-Pozza (L)

Cancer Centre for Children, Children's Hospital at Westmead, Westmead, New South Wales, Australia.

Madlen Gazarian (M)

Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.

Peter J Gates (PJ)

Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.

Valentina Lichtner (V)

Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.
School of Pharmacy, University College London, London, UK.

Peter Barclay (P)

Department of Pharmacy, Children's Hospital at Westmead, Westmead, New South Wales, Australia.

Alan Gardo (A)

Nursing Department, Children's Hospital at Westmead, Westmead, New South Wales, Australia.

Mark Wiggins (M)

Department of Pyschology, Macquarie University, Sydney, New South Wales, Australia.

Leslie White (L)

Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH